Director, Urology and Renal Transplantation, Pelvic Floor and Neuro-Urology Clinic, Jaslok Hospital and Research Centre; Senior Visiting Urologis, Sir H.N. Reliance Hospital, Lilavati Hospital, Breach Candy Hospital and Wockhardt Hospital, Mumbai, Maharashtra, India.
Neurol India. 2020 Nov-Dec;68(Supplement):S307-S315. doi: 10.4103/0028-3886.302457.
Control of the lower urinary tract is a complex, multilevel process that involves the peripheral and central nervous systems. Patients with spinal cord diseases or injuries present with multiple bladder and bowel problems. The commonest are urinary, urgency, frequency, urge incontinence, retention and/or fecal incontinence. Though the first reports of neurostimulation to empty bladder came in 1970s', it was only in 1988 that Schmidt and Tanagho restarted discussion and application of neuromodulation and electrical stimulation of sacral nerve in urology. In April, 1999 - FDA approved the InterStim System for treatment of symptoms of urgency-frequency and urinary retention. In October 2000, Medtronic Commercial Release for SNS-Bowel was approved. In October 2002, the Tined lead was launched and N'Vision programmer was launched in the official market in Europe. SNM is now considered the third line of management in refractory cases of OAB, chronic NOUR, frequency and urgency. Role in neuropathic bladder is still being assessed. SNM includes a thorough preoperative assessment, PNE (Percutaneous Nerve Evaluation) without any muscle relaxation and finally installation of a permanent IPG after assessing reponse. We have an experience of over 20 patients in last 11 years. These include patients of refractory OAB, chronic NOUR and Cauda Equina Syndrome. We do a two-staged procedure in view of the high cost and abide by the AUA, EAU and ICS guidelines. Our long term results for neuropathic OAB are awaited.
下尿路的控制是一个复杂的多水平过程,涉及外周和中枢神经系统。患有脊髓疾病或损伤的患者会出现多种膀胱和肠道问题。最常见的是尿失禁、尿急、尿频、急迫性尿失禁、尿潴留和/或粪便失禁。尽管早在 20 世纪 70 年代就有关于神经刺激排空膀胱的首次报道,但直到 1988 年,Schmidt 和 Tanagho 才重新开始讨论和应用骶神经调节和电刺激在泌尿科中的应用。1999 年 4 月,FDA 批准了 InterStim 系统用于治疗尿急-尿频和尿潴留症状。2000 年 10 月,Medtronic 商业发布了 SNS-Bowel。2002 年 10 月,推出了 Tined 导联,在欧洲正式市场推出了 N'Vision 编程器。SNM 现在被认为是难治性逼尿症、慢性非阻塞性尿潴留、尿频和尿急的第三线治疗方法。在神经源性膀胱中的作用仍在评估中。SNM 包括彻底的术前评估、PNE(经皮神经评估)而无需任何肌肉松弛,最后在评估反应后安装永久性 IPG。在过去的 11 年中,我们有超过 20 名患者的经验。这些患者包括难治性逼尿症、慢性非阻塞性尿潴留和马尾综合征。鉴于成本较高,我们采用两阶段手术,并遵守 AUA、EAU 和 ICS 指南。我们正在等待神经源性逼尿症的长期结果。